These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15588860)

  • 1. Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses).
    Panagopoulos I; Mertens F; Isaksson M; Mandahl N
    Cancer Genet Cytogenet; 2005 Jan; 156(1):74-6. PubMed ID: 15588860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts).
    Langezaal SM; Graadt van Roggen JF; Cleton-Jansen AM; Baelde JJ; Hogendoorn PC
    Br J Cancer; 2001 Feb; 84(4):535-8. PubMed ID: 11207050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma.
    Yang L; Chen Y; Cui T; Knösel T; Zhang Q; Geier C; Katenkamp D; Petersen I
    Hum Pathol; 2012 Sep; 43(9):1463-70. PubMed ID: 22406360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant melanoma of the soft parts (clear-cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation.
    Speleman F; Delattre O; Peter M; Hauben E; Van Roy N; Van Marck E
    Mod Pathol; 1997 May; 10(5):496-9. PubMed ID: 9160316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopathological entities.
    Graadt van Roggen JF; Mooi WJ; Hogendoorn PC
    J Pathol; 1998 Sep; 186(1):3-7. PubMed ID: 9875133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
    Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
    Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of V599E BRAF mutations in desmoplastic melanomas.
    Davison JM; Rosenbaum E; Barrett TL; Goldenberg D; Hoque MO; Sidransky D; Westra WH
    Cancer; 2005 Feb; 103(4):788-92. PubMed ID: 15641040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
    Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
    Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses.
    Panagopoulos I; Mertens F; Dêbiec-Rychter M; Isaksson M; Limon J; Kardas I; Domanski HA; Sciot R; Perek D; Crnalic S; Larsson O; Mandahl N
    Int J Cancer; 2002 Jun; 99(4):560-7. PubMed ID: 11992546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EWS-ATF1 fusion transcripts in gastrointestinal tumors previously diagnosed as malignant melanoma.
    Covinsky M; Gong S; Rajaram V; Perry A; Pfeifer J
    Hum Pathol; 2005 Jan; 36(1):74-81. PubMed ID: 15712185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
    Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
    Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of BRAF mutations in uveal melanoma.
    Rimoldi D; Salvi S; Liénard D; Lejeune FJ; Speiser D; Zografos L; Cerottini JC
    Cancer Res; 2003 Sep; 63(18):5712-5. PubMed ID: 14522889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clear cell sarcoma of tendons and aponeuroses, and osteoclast-rich tumour of the gastrointestinal tract with features resembling clear cell sarcoma of soft parts: a review and update.
    Kosemehmetoglu K; Folpe AL
    J Clin Pathol; 2010 May; 63(5):416-23. PubMed ID: 20418233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma.
    Mihic-Probst D; Perren A; Schmid S; Saremaslani P; Komminoth P; Heitz PU
    Anticancer Res; 2004; 24(4):2415-8. PubMed ID: 15330192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.
    Indsto JO; Kumar S; Wang L; Crotty KA; Arbuckle SM; Mann GJ
    J Cutan Pathol; 2007 Jun; 34(6):448-55. PubMed ID: 17518771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the mitogen-activated protein kinase pathway in malignant melanoma can occur independently of the BRAF T1799A mutation.
    Yazdi AS; Ghoreschi K; Sander CA; Röcken M
    Eur J Dermatol; 2010; 20(5):575-9. PubMed ID: 20605766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear cell melanoma: a cutaneous clear cell malignancy.
    Pletneva MA; Andea A; Palanisamy N; Betz BL; Carskadon S; Wang M; Patel RM; Fullen DR; Harms PW
    Arch Pathol Lab Med; 2014 Oct; 138(10):1328-36. PubMed ID: 25268196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep intronic point mutations of the KIT gene in a female patient with cutaneous clear cell sarcoma and her family.
    Gambichler T; Pantelaki I; Othlinghaus N; Moritz RK; Stricker I; Skrygan M
    Cancer Genet; 2012 Apr; 205(4):182-5. PubMed ID: 22559980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors.
    Sharma A; Trivedi NR; Zimmerman MA; Tuveson DA; Smith CD; Robertson GP
    Cancer Res; 2005 Mar; 65(6):2412-21. PubMed ID: 15781657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMSP tumor cells expressing the EWS/ATF1 oncogene do not support cAMP-inducible transcription.
    Li KK; Lee KA
    Oncogene; 1998 Mar; 16(10):1325-31. PubMed ID: 9546434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.